SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARADIGM CORP. ARDM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (50)12/12/1999 2:34:00 PM
From: rkrw  Read Replies (1) of 255
 
I've had Aradigm pegged as a 2H 2000 stock. A few key milestones should start hitting around then, not the least of which is insulin Ph III.
One criticism I have is that management needs to do a better job disclosing data fairly. They failed to disclose the delays in their morphine program as the CEO pegged it as "non material" yet it took the stock down from $10 to $6 as they selectively disclosed the news to analysts. That's bullshit in my book.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News